Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 4-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Celecoxib: a model therapy for RA and OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. :
Modest BP changes greatly affect CV risk, cost burden in OA, RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 411, 2003-01 ,pp. :